CAS 452342-37-9

Formula: C19H14N4

InChI: InChI=1S/C19H14N4/c1-2-6-14(7-3-1)18-12-15(9-11-21-18)16-13-22-23-19(16)17-8-4-5-10-20-17/h1-13H,(H,22,23)

InChI key: BDCBRQYHYNUWAM-UHFFFAOYSA-N

SMILES: C1=CC=C(C=C1)C2=NC=CC(=C2)C3=C(NN=C3)C4=CC=CC=N4

GW-6604

CAS: 452342-37-9

GW-6604

Formula: C₁₉H₁₄N₄

Purity: 99.5%

Molecular weight: 298.34

Ref: 54-BUP08375

GW-6604

CAS: 452342-37-9

Formula: C₁₉H₁₄N₄

Molecular weight: 298.3413

Ref: IN-DA00DFKT

2-Phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine

CAS: 452342-37-9

2-Phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine is a synthetic small molecule that binds to the GABA receptor. It has been shown to act as an ion channel inhibitor and is currently being researched for its potential use in treating epilepsy, anxiety, and sleep disorders. 2-Phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine binds to the GABA receptor with high affinity and specificity. This compound has been shown to be a potent antagonist of the GABA receptor, with K i values of 0.14 nM and 0.17 nM for rat and human receptors respectively. 2Phenyl 4-(3 pyridin 2 yl 1 H pyrazol 4 yl) pyridine also acts as an agonist at recombinant human GABAA receptors containing alpha5

Formula: C₁₉H₁₄N₄

Purity: Min. 95%

Molecular weight: 298.3 g/mol

Ref: 3D-CTA34237

GW-6604

CAS: 452342-37-9

GW-6604 is an ALK5 inhibitor and shows clear antifibrotic effects resulting in liver function improvement.

Formula: C₁₉H₁₄N₄

Purity: 99.6%

Color and Shape: Yellow Solid

Molecular weight: 298.3413

Ref: TM-T9947